NATO Defense Spending Surge and US Troop Deployment to Poland Signal Shift in European Security Space Stocks Surge as SpaceX IPO Speculation Intensifies JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI What Investors Should Know Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Returns by 2030 SpaceX Launches Upgraded Starship in 12th Test Flight as Public Listing Looms Deepa Jewellers and Cotec Healthcare Secure SEBI Approval for Initial Public Offerings ALMS Q1 2026 Earnings EPS Beat Partially Offsets Investor Concerns JELD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions STVN Q1 2026 Earnings EPS Beats Estimates by 5 Stock Rises FCFS Q1 2026 Earnings DoubleDigit EPS Beat Drives Modest Share Gains LGIH Q1 2026 Earnings Massive EPS Beat Surprises the Market HUN Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction GigaMedia GIGM Holds Steady at 149 as Range Tightens 4D Molecular Therapeutics FDMT Surges 310 Biotech Momentum Builds Ellington Credit Company EARN Bounces Modestly Support Holds Near 457 SAJ Notes Hold Steady at 254 Yield Advantage and Key Technical Levels in Focus W P Carey Inc WPC Shows Modest Gains as REIT Sector Navigates Interest Rate Uncertainty Via Transportation Inc VIA Q1 2026 Earnings Narrower Loss Beats Estimates Amid Strategic Shift HIMX Q1 2026 Earnings Slight EPS Beat Drives Positive Market Reaction BKH Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower SGI Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Declines Modestly ASR Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Weigh PHAT Q1 2026 Earnings EPS Misses Estimates Amid Continued RD Investment JPMorgan Chase Declares Quarterly Dividend of 150 Per Share OI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips Intercontinental Exchange ICE Edges Higher Amid Positive Volume Trends ZVRA Q1 2026 Earnings Strong EPS Beat Driven by NonOperating Items SRRK Q1 2026 Earnings Narrowed EPS Miss and Steady Pipeline Progress Amid No Revenue Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported BIP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage IGC Q1 2026 Earnings EPS Surpasses Estimates by 1416 Amid Revenue Challenges BNR Q3 2022 Earnings NarrowerThanExpected Loss as Biotech Company Navigates Challenges